U.S.-based precision diagnostics company Epredia is optimistic about the future of the Chinese mainland's healthcare sector. Steven Lynum, the company's president, highlighted the unique aspects of this market that make it ripe for growth.
The Chinese mainland's healthcare market is expected to expand by approximately 7 percent in 2024, marking it as a significant player in the global health landscape. This growth presents considerable opportunities for businesses looking to establish or expand their presence in the region.
\"Providing more products that are manufactured in the Chinese mainland and can support the local market is a huge opportunity,\" said Lynum. He emphasized the importance of tailoring offerings to meet the specific needs of the Chinese mainland’s healthcare sector, leveraging local manufacturing capabilities to drive success.
Reference(s):
cgtn.com
